申请人:Bayer Pharma Aktiengesellschaft
公开号:US20170081315A1
公开(公告)日:2017-03-23
A compound of formula Ia:
The present invention relates to novel indazolyl derivatives, to pharmaceutical compositions comprising such derivatives, to processes for preparing such novel derivatives and to the use of such derivatives as medicaments